Mirabella Financial Services’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Mirabella Financial Services’s Portfolio CNCE Stock Details CNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-15,410	Closed	-$90K	–	638
2022 Q4	$90K	Buy	+15,410	New	+$81K	0.01%	348

Mirabella Financial Services's CNCE Position: Q1 2023 in Review

Mirabella Financial Services sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q1 2023, closing a stake of 15,410 shares — an estimated $90K sold.

Mirabella Financial Services first reported a position in CNCE in Q4 2022 and held it in 1 quarter. The position peaked at $90K in Q4 2022. 0 funds tracked by Wall St. Rank hold CNCE as of Q1 2023.

Mirabella Financial Services reported no remaining Concert Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
Mirabella Financial Services sold 15,410 Concert Pharmaceuticals, Inc. shares in Q1 2023, an estimated $90K.
Mirabella Financial Services first reported a position in Concert Pharmaceuticals, Inc. in Q4 2022 and held it in 1 quarter.
Mirabella Financial Services's Concert Pharmaceuticals, Inc. position peaked at $90K in Q4 2022.
0 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q1 2023.

Based on Mirabella Financial Services's 13F filing for Q1 2023, filed 12 May 2023.